NASS 2022: A Conversation with ZimVie

Orthopedic Market Growth

During our visit to NASS this year, we sat down with Rebecca Whitney, Global Spine President at ZimVie. We talked about the company’s progress in untangling itself from Zimmer Biomet, attractive markets outside of the United States and ZimVie’s medium-term priorities. An excerpt of our conversion follows.

ORTHOWORLD: You’ve been very busy...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us